Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Z. Harsanyi"'
Autor:
C Cloutier, J Taliano, W O’Mahony, M Csanadi, G Cohen, I Sutton, D Sinclair, M Awde, S Henein, L Robinson, J Eisenhoffer, PS Piraino, Z Harsanyi, KJ Michalko
Publikováno v:
Pain Research and Management, Vol 18, Iss 2, Pp 75-82 (2013)
BACKGROUND: For Canadian regulatory purposes, an analgesic study was required to complement previously completed, pivotal studies on bowel effects and analgesia associated with controlled-release (CR) oxycodone/CR naloxone.
Externí odkaz:
https://doaj.org/article/2cbdd8a354f6427bb8a9b6620f88f6e9
Autor:
J Côté, R. N. Rivington, A C Darke, H Kreisman, M Alexander, Z Harsanyi, Louis-Philippe Boulet, A Day, D I Small
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 151:325-332
A group of 32 patients with moderately severe, chronic asthma (mean FEV1 55% of predicted), maintained on moderately high doses of inhaled corticosteroids (mean dose 1,100 micrograms/d), participated in this double-blind, placebo-controlled crossover
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 7(4)
We evaluated the safety and efficacy of controlled-release morphine sulphate suppositories administered 12-hourly and once daily in patients with chronic cancer in a randomized double-blind crossover trial. Pain was assessed using a 100-mm VAS pain s
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 69:S125-S126
Autor:
E D, Bruera, T J, MacEachern, K A, Spachynski, D F, LeGatt, R N, MacDonald, N, Babul, Z, Harsanyi, A C, Darke
Publikováno v:
Cancer. 74(12)
The short elimination half-life of metoclopramide necessitates frequent administration for optimal relief of nausea. This study compares a newly developed controlled release preparation of metoclopramide (CRM) and immediate release metoclopramide (IR
Publikováno v:
Cancer. 74(6)
The short elimination half-life of hydromorphone necessitates 4-hourly dosing to maintain optimal levels of analgesia in patients with chronic cancer pain. The purpose of this study was to compare the clinical efficacy and safety of controlled releas
Autor:
J. Eisenhoffer, A. Beaulieu, Paul M. Peloso, J. Wade, A. C. Darke, Z. Harsanyi, D. O’Hanlon, Glen T. D. Thomson, W. Bensen, P. Quigley
Publikováno v:
The Journal of Pain. 5:S72
Publikováno v:
Clinical Pharmacology & Therapeutics. 73:P9-P9
Publikováno v:
Canadian journal of public health = Revue canadienne de sante publique. 75(6)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.